InnoCare Pharma Limited (SHA:688428)
China · Delayed Price · Currency is CNY 25.34
+0.17 (0.68%)
At close: Nov 14, 2025
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 26.58 billion as of November 14, 2025. Its market cap has increased by 111.70% in one year.
Market Cap
26.58B
Enterprise Value
20.84B
Revenue
1.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
25.34
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 11.23B to 26.58B, an increase of 136.80%. That is a compound annual growth rate of 16.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 26.58B | 131.48% |
| Dec 31, 2024 | 11.48B | -3.51% |
| Dec 29, 2023 | 11.90B | -42.63% |
| Dec 30, 2022 | 20.74B | 20.72% |
| Dec 31, 2021 | 17.18B | 17.44% |
| Dec 31, 2020 | 14.63B | 30.36% |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 417.34B |
| WuXi AppTec | 282.16B |
| Shenzhen Mindray Bio-Medical Electronics | 251.19B |
| Sichuan Biokin Pharmaceutical | 153.43B |
| Aier Eye Hospital Group | 113.87B |
| Shanghai United Imaging Healthcare | 112.24B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.07B |
| Yunnan Baiyao Group Co.,Ltd | 101.10B |